Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
The Factor V activity test measures how well factor V, a clotting protein made in the liver, functions in your blood. It uses a clot-based method that compares your plasma to a normal reference, and reports the result in units per milliliter.
The notation 1:40 refers to a standard dilution of your plasma used by the laboratory to optimize accuracy and comparability. This test is commonly performed when initial clotting screens such as the PT or aPTT are abnormal, or when there are signs or symptoms of a bleeding tendency.
Too little factor V activity can be linked to easy bruising, nosebleeds, heavy menstrual bleeding, bleeding after procedures, or less commonly deep tissue bleeds. Low activity may be inherited or acquired due to conditions such as significant liver disease, disseminated intravascular coagulation, certain autoimmune inhibitors, or dilution after major transfusion.
Your clinician may order this test to investigate prolonged screening tests, a personal or family history of bleeding, or to assess for an inhibitor against factor V. Higher than expected results are uncommon and usually not worrisome on their own; they can reflect acute inflammation or technical issues rather than a true tendency toward clotting.
If your activity is lower than expected, your clinician may repeat the test, review medications, and consider a mixing study to see whether adding normal plasma corrects the clotting time. Correction points toward a deficiency, while lack of correction suggests an inhibitor. Additional evaluations, such as other factor levels and liver function tests, may help determine the cause and guide treatment.
If your activity is within the expected range, it supports normal factor V function. If it is higher than expected, your clinician will interpret it in context, considering acute illness or assay interference. Results are best understood together with your symptoms, other coagulation tests, and medical history. Do not start or stop medications without medical advice.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Underfilled citrate tubes, difficult draws, heparin contamination from lines, or delays in processing can falsely alter activity results. Proper fill, prompt centrifugation, and avoiding line draws when possible help ensure accuracy.
Heparin and some direct oral anticoagulants can interfere with clot-based assays and make factor activity appear lower than it truly is. Warfarin typically does not lower factor V because this factor is not vitamin K dependent.
Because factor V is made in the liver, significant liver dysfunction can reduce activity. Conditions that consume clotting factors, such as disseminated intravascular coagulation, can also lower measured levels.
Acquired inhibitors to factor V may develop after exposure to certain surgical materials, infections, or medications. These antibodies interfere with function and are often detected by a mixing study that fails to correct.
Recent transfusion of plasma or large volumes of intravenous fluids can temporarily change measured activity by replacing or diluting your own clotting factors. Timing of the blood draw relative to transfusion matters.
Physiologic changes in newborns, pregnancy, or acute illness can influence clotting tests and the way the assay behaves. Your clinician will interpret results in the context of these situations and your overall health.
References